Case number 2018-1434
Novartis Pharmaceuticals Corp v. West-Ward Pharmaceuticals > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | NOVARTIS PHARMACEUTICALS CORP v. WEST-WARD PHARMACEUTICALS [OPINION - PRECEDENTIAL] [precedential] (0) |
| Jun 19, 2019 | 63 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [615413] [JAB] [Entered: 06/19/2019 10:03 AM] (1) |
| May 13, 2019 | 62 | JUDGMENT filed. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [606763] [JAB] [Entered: 05/13/2019 09:44 AM] (2) |
| May 13, 2019 | 61 | OPINION filed for the court by Stoll, Circuit Judge; Plager, Circuit Judge and Clevenger, Circuit Judge. Precedential Opinion. [606762] [JAB] [Entered: 05/13/2019 09:44 AM] (20) |
| Mar 26, 2019 | 60 | Letter from Appellant West-Ward Pharmaceuticals International Limited. Service: 03/29/2019 by clerk. [596592] [JAB] [Entered: 03/29/2019 03:18 PM] (3) |
| Jan 9, 2019 | 59 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: certificate of interest Docket No. [58], ERROR: Name of party represented (item no. 1) does not match official caption. CORRECTION: In the future, counsel must either use party name as seen in official caption or move to have the caption revised. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [576860] [JAB] [Entered: 01/09/2019 10:57 AM] (0) |
| Jan 9, 2019 | 58 | Amended Certificate of Interest for the Appellant West-Ward Pharmaceuticals International Limited. Service: 01/09/2019 by email. [576847] [18-1434] [William Jay] [Entered: 01/09/2019 10:39 AM] (3) |
| Dec 3, 2018 | 57 | Submitted after ORAL ARGUMENT by David Zimmer for West-Ward Pharmaceuticals International Limited and Christina A. L. Schwarz for Novartis AG and Novartis Pharmaceuticals Corporation. Panel: Judge: Stoll , Judge: Plager , Judge: Clevenger. [569232] [JAB] [Entered: 12/03/2018 12:22 PM] (0) |
| Nov 15, 2018 | 56 | Response to oral argument order from the Appellees Novartis AG and Novartis Pharmaceuticals Corporation.[565487] [18-1434] [Christina Schwarz] [Entered: 11/15/2018 04:07 PM] (3) |
| Nov 15, 2018 | 55 | Response to oral argument order from the Appellant West-Ward Pharmaceuticals International Limited.[565400] [18-1434] [David Zimmer] [Entered: 11/15/2018 03:08 PM] (3) |
| Nov 7, 2018 | 54 | Amended Entry of appearance for Laura K. Fishwick as of counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 11/07/2018 by email. [563178] [18-1434] [Shannon Clark] [Entered: 11/07/2018 10:07 AM] (3) |
| Nov 7, 2018 | 53 | Amended Entry of appearance for Shannon K. Clark as of counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 11/07/2018 by email. [563177] [18-1434] [Shannon Clark] [Entered: 11/07/2018 10:06 AM] (3) |
| Nov 7, 2018 | 52 | Amended Entry of appearance for Susanne L. Flanders as of counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 11/07/2018 by email. [563175] [18-1434] [Shannon Clark] [Entered: 11/07/2018 10:04 AM] (3) |
| Nov 7, 2018 | 51 | Amended Entry of appearance for Jared L. Stringham as of counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 11/07/2018 by email. [563173] [18-1434] [Shannon Clark] [Entered: 11/07/2018 10:02 AM] (3) |
| Nov 7, 2018 | 50 | Amended Entry of appearance for Christina Schwarz as of counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 11/07/2018 by email. [563170] [18-1434] [Shannon Clark] [Entered: 11/07/2018 10:01 AM] (3) |
| Nov 7, 2018 | 49 | Amended Entry of appearance for Nicholas N. Kallas as principal counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 11/07/2018 by email. [563168] [18-1434] [Shannon Clark] [Entered: 11/07/2018 09:59 AM] (3) |
| Oct 22, 2018 | 48 | NOTICE OF ORAL ARGUMENT. Panel: 1812C. Case scheduled Dec 03, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 11/15/2018. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [559066] [JAB] [Entered: 10/22/2018 11:21 AM] (2) |
| Oct 16, 2018 | 47 | Notice from Appellant West-Ward Pharmaceuticals International Limited regarding conflicts with oral argument (December 4, 2018; February 8, 2019). Service: 10/16/2018 by email. [557436] [18-1434] [William Jay] [Entered: 10/16/2018 10:14 AM] (2) |
| Jul 26, 2018 | 46 | **TEXT ONLY** ORDER granting motion to withdraw attorney [45] Charlotte Jacobsen filed by Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [538856] [SJ] [Entered: 07/26/2018 04:34 PM] (0) |
| Jul 26, 2018 | 45 | MOTION of Appellees Novartis AG and Novartis Pharmaceuticals Corporation to withdraw counsel Charlotte Jacobsen [Consent: unopposed]. Service: 07/26/2018 by email. [538768] [18-1434] [Christina Schwarz] [Entered: 07/26/2018 01:52 PM] (6) |
| Jul 3, 2018 | 44 | Certificate of Interest for the Appellant West-Ward Pharmaceuticals International Limited. Service: 07/03/2018 by email. [533597] [18-1434] [Keith Zullow] [Entered: 07/03/2018 05:57 PM] (3) |
| Jun 26, 2018 | 43 | Notice from Appellees Novartis AG and Novartis Pharmaceuticals Corporation regarding conflicts with oral argument (Counsel for Plaintiffs-Appellees are not available for argument during the September 4-7, 2018, or October 1-5, 2018 sessions.). Service: 06/26/2018 by clerk. [531973] [18-1434] [Shannon Clark] [Entered: 06/26/2018 12:40 PM] (2) |
| Jun 25, 2018 | 42 | Notice from Appellant West-Ward Pharmaceuticals International Limited regarding conflicts with oral argument (August 6, August 10 and September 4). Service: 06/25/2018 by email. [531743] [18-1434] [William Jay] [Entered: 06/25/2018 03:23 PM] (2) |
| Jun 21, 2018 | 41 | 6 paper copies of the Joint Appendix Brief [39] received from Appellant West-Ward Pharmaceuticals International Limited. [531255] [CJF] [Entered: 06/21/2018 01:35 PM] (0) |
| Jun 19, 2018 | 40 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category.. [530617] [SJ] [Entered: 06/19/2018 02:50 PM] (0) |
| Jun 15, 2018 | 39 | APPENDIX FILED for West-Ward Pharmaceuticals International Limited [38]. Number of Pages: 539. Service: 06/15/2018 by email. The paper copies of the brief should be received by the court on or before 06/26/2018. [530616] [SJ] [Entered: 06/19/2018 02:49 PM] (541) |
| Jun 15, 2018 | 38 | TENDERED from Appellees Novartis AG, Novartis Pharmaceuticals Corporation and Appellant West-Ward Pharmaceuticals International Limited. Title: JOINT APPENDIX. Service: 06/15/2018 by email. [529738] [18-1434] [William Jay] [Entered: 06/15/2018 10:33 AM] (541) |
| Jun 15, 2018 | 37 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellees Novartis AG, Novartis Pharmaceuticals Corporation and Appellant West-Ward Pharmaceuticals International Limited. Service: 06/15/2018 by email. [529734] [18-1434] [William Jay] [Entered: 06/15/2018 10:29 AM] (3) |
| Jun 13, 2018 | 36 | 6 paper copies of the Reply Brief [35] received from Appellant West-Ward Pharmaceuticals International Limited. [529120] [CJF] [Entered: 06/13/2018 01:35 PM] (0) |
| Jun 11, 2018 | 35 | REPLY BRIEF FILED for Appellant West-Ward Pharmaceuticals International Limited [34]. Number of Pages: 30. Service: 06/11/2018 by email. The paper copies of the brief should be received by the court on or before 06/19/2018. Appendix is due 06/18/2018. [528818] [CFT] [Entered: 06/12/2018 02:33 PM] (41) |
| Jun 11, 2018 | 34 | TENDERED from Appellant West-Ward Pharmaceuticals International Limited. Title: REPLY BRIEF. Service: 06/11/2018 by email. [528552] [18-1434] [William Jay] [Entered: 06/11/2018 06:23 PM] (41) |
| May 25, 2018 | 33 | **TEXT ONLY** ORDER granting motion to extend time to file brief [31] filed by Appellant West-Ward Pharmaceuticals International Limited. Reply brief is due 06/11/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [524682] [SJ] [Entered: 05/25/2018 11:22 AM] (0) |
| May 24, 2018 | 32 | 6 paper copies of the Opening Response Brief [30] received from Appellees Novartis AG and Novartis Pharmaceuticals Corporation. [524574] [JCP] [Entered: 05/25/2018 07:16 AM] (0) |
| May 24, 2018 | 31 | MOTION of Appellant West-Ward Pharmaceuticals International Limited to extend the time to 06/11/2018 to file the Reply Brief. [Consent: unopposed]. Service: 05/24/2018 by email. [524512] [18-1434] [William Jay] [Entered: 05/24/2018 04:41 PM] (7) |
| May 21, 2018 | 30 | BRIEF FILED for Appellees Novartis AG and Novartis Pharmaceuticals Corporation [29]. Number of Pages: 62. Service: 05/21/2018 by email. The paper copies of the brief should be received by the court on or before 05/31/2018. Appellant West-Ward Pharmaceuticals International Limited reply brief is due 06/04/2018. [523973] [SJ] [Entered: 05/23/2018 01:57 PM] (77) |
| May 21, 2018 | 29 | TENDERED from Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Title: RESPONSE BRIEF. Service: 05/21/2018 by email. [523424] [18-1434] [Shannon Clark] [Entered: 05/21/2018 06:46 PM] (77) |
| May 18, 2018 | 28 | Entry of appearance for Shannon K. Clark as of counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 05/18/2018 by email. [522911] [18-1434] [Shannon Clark] [Entered: 05/18/2018 01:56 PM] (3) |
| Apr 11, 2018 | 27 | **TEXT ONLY** ORDER granting motion to extend time to file response brief [26] filed by Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Appellees Novartis AG and Novartis Pharmaceuticals Corporation brief due 05/21/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [512316] [SJ] [Entered: 04/11/2018 09:52 AM] (0) |
| Apr 10, 2018 | 26 | MOTION of Appellees Novartis AG and Novartis Pharmaceuticals Corporation to extend the time to 05/21/2018 to file the Responsive Brief.. Any response is due within 10 days of service. [Consent: unopposed]. Service: 04/10/2018 by email. [512221] [18-1434] [Christina Schwarz] [Entered: 04/10/2018 04:52 PM] (9) |
| Apr 5, 2018 | 25 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Nicholas Kallas and Susanne Flanders (entries of appearance [3] and [6]) are not registered CM/ECF filers for the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. [511073] [MJL] [Entered: 04/05/2018 06:44 PM] (0) |
| Mar 23, 2018 | 24 | 6 paper copies of the Opening Brief [23] received from Appellant West-Ward Pharmaceuticals International Limited. [507748] [SJL] [Entered: 03/26/2018 08:31 AM] (0) |
| Mar 20, 2018 | 23 | BRIEF FILED for Appellant West-Ward Pharmaceuticals International Limited [22]. Number of Pages: 64. Service: 03/20/2018 by email. The paper copies of the brief should be received by the court on or before 03/28/2018. Appellees' brief is due 04/30/2018. [506952] [MJL] [Entered: 03/21/2018 04:14 PM] (142) |
| Mar 20, 2018 | 22 | TENDERED from Appellant West-Ward Pharmaceuticals International Limited. Title: OPENING BRIEF. Service: 03/20/2018 by email. [506787] [18-1434] [William Jay] [Entered: 03/20/2018 05:14 PM] (142) |
| Feb 7, 2018 | 21 | Entry of appearance for Cindy Chang as of counsel for Appellant West-Ward Pharmaceuticals International Limited. Service: 02/06/2018 by email. [495870] [Cindy Chang] [Entered: 02/07/2018 11:54 AM] (2) |
| Feb 7, 2018 | 20 | Amended Certificate of Interest for the Appellant West-Ward Pharmaceuticals International Limited. Service: 02/07/2018 by email. [495869] [Keith Zullow] [Entered: 02/07/2018 11:47 AM] (4) |
| Feb 5, 2018 | 19 | Corrected Certificate of Interest for the Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 02/05/2018 by email. [495305] [Jared Stringham] [Entered: 02/05/2018 04:43 PM] (3) |
| Feb 5, 2018 | 18 | NOTICE OF DEFICIENCY: The certificate of interest Document No. [9] filed by Appellees Novartis AG and Novartis Pharmaceuticals Corporation in 18-1434 is incomplete. Item #5 was not included on the form (the form is outdated). As of 10/02/2017, all COIs must adhere to FCR 47.4 as amended and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [495143] [FMS] [Entered: 02/05/2018 01:34 PM] (0) |
| Feb 2, 2018 | 17 | Certificate of Interest for the Appellant West-Ward Pharmaceuticals International Limited. Service: 02/02/2018 by email. [494961] [Keith Zullow] [Entered: 02/02/2018 04:58 PM] (3) |
| Feb 2, 2018 | 16 | Docketing Statement for the Appellant West-Ward Pharmaceuticals International Limited. Service: 02/02/2018 by email. [494960] [Keith Zullow] [Entered: 02/02/2018 04:57 PM] (3) |
| Feb 2, 2018 | 15 | Entry of appearance for David Zimmer as of counsel for Appellant West-Ward Pharmaceuticals International Limited. Service: 02/02/2018 by email. [494959] [David Zimmer] [Entered: 02/02/2018 04:54 PM] (2) |
| Feb 2, 2018 | 14 | Entry of appearance for Natasha Daughtrey as of counsel for Appellant West-Ward Pharmaceuticals International Limited. Service: 02/02/2018 by email. [494958] [Natasha Daughtrey] [Entered: 02/02/2018 04:51 PM] (2) |
| Feb 2, 2018 | 13 | Entry of appearance for Steven J. Bernstein as of counsel for Appellant West-Ward Pharmaceuticals International Limited. Service: 02/02/2018 by email. [494957] [Steven Bernstein] [Entered: 02/02/2018 04:49 PM] (2) |
| Feb 2, 2018 | 12 | Entry of appearance for Michael B. Cottler as of counsel for Appellant West-Ward Pharmaceuticals International Limited. Service: 02/02/2018 by email. [494956] [Michael Cottler] [Entered: 02/02/2018 04:46 PM] (2) |
| Feb 2, 2018 | 11 | Entry of appearance for William M. Jay as of counsel for Appellant West-Ward Pharmaceuticals International Limited. Service: 02/02/2018 by email. [494955] [William Jay] [Entered: 02/02/2018 04:43 PM] (2) |
| Feb 2, 2018 | 10 | Entry of appearance for Keith A. Zullow as principal counsel for Appellant West-Ward Pharmaceuticals International Limited. Service: 02/02/2018 by email. [494953] [Keith Zullow] [Entered: 02/02/2018 04:40 PM] (2) |
| Feb 2, 2018 | 9 | Certificate of Interest for the Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 02/02/2018 by email. [494940] [Jared Stringham] [Entered: 02/02/2018 04:15 PM] (0) |
| Feb 2, 2018 | 8 | Entry of appearance for Laura Fishwick as of counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 02/02/2018 by email. [494939] [Jared Stringham] [Entered: 02/02/2018 04:14 PM] (3) |
| Feb 2, 2018 | 7 | Entry of appearance for Jared Stringham as of counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 02/02/2018 by email. [494938] [Jared Stringham] [Entered: 02/02/2018 04:13 PM] (3) |
| Feb 2, 2018 | 6 | Entry of appearance for Susanne Flanders as of counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 02/02/2018 by email. [494937] [Jared Stringham] [Entered: 02/02/2018 04:12 PM] (3) |
| Feb 2, 2018 | 5 | Entry of appearance for Christina Schwarz as of counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 02/02/2018 by email. [494936] [Jared Stringham] [Entered: 02/02/2018 04:12 PM] (3) |
| Feb 2, 2018 | 4 | Entry of appearance for Charlotte Jacobsen as of counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 02/02/2018 by email. [494935] [Jared Stringham] [Entered: 02/02/2018 04:11 PM] (3) |
| Feb 2, 2018 | 3 | Entry of appearance for Nicholas Kallas as principal counsel for Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 02/02/2018 by email. [494932] [Jared Stringham] [Entered: 02/02/2018 04:10 PM] (3) |
| Feb 2, 2018 | 2 | Docketing Statement for the Appellees Novartis AG and Novartis Pharmaceuticals Corporation. Service: 02/02/2017 by email. [494930] [Jared Stringham] [Entered: 02/02/2018 04:08 PM] (5) |
| Jan 19, 2018 | 1 | Appeal docketed. Received: 01/17/2018. [490918]Entry of Appearance due 02/02/2018. Certificate of Interest is due on 02/02/2018. Docketing Statement due 02/02/2018. Appellant/Petitioner's brief is due 03/20/2018. [FMS] [Entered: 01/19/2018 12:38 PM] (65) |
